top of page

Arthur L. Brody

Arthur L. Brody


  • Board Certification, American Board of Psychiatry and Neurology

  • Board Certification, Addiction Psychiatry

Current Position(s): 

  • Research Psychiatrist, VA San Diego Healthcare System

  • Research Scientist, Veterans Medical Research Foundation

  • Professor-in-Residence, UCSD Department of Psychiatry

  • Medical Director, Alcohol and Drug Treatment Smoking Cessation Program, VA San Diego Healthcare System

Personal Statement: 

Dr. Brody’s research career has focused on brain imaging and treatment of cigarette smokers.  In previous studies, his group has used positron emission tomography (PET) scanning to examine the effects of smoking on glucose metabolism, dopamine receptor availability, nicotinic acetylcholine receptor (nAChR) availability, and neuroinflammation.  In these contexts, his research has demonstrated effects of smoking and cessation on smoking-induced dopamine release, nAChR availability, nAChR occupancy, and inflammation.  As director of smoking cessation programs at the VA San Diego Healthcare System (and formerly the VA Greater Los Angeles), he has treated approximately 6000 cigarette smokers (and other tobacco/nicotine users).  As PI for the proposed PET and treatment research, he oversees and coordinates all aspects of study implementation, including participant recruitment, initial evaluations, rating scale administration, PET and magnetic resonance imaging sessions, evaluations of smoking status, complying with all regulatory requirements, statistical analysis of data, and preparation of data for scientific meeting and manuscript presentations.

Professional History:

  • UCLA Psychiatry Residency (and Research Track) Applicant Interviewer, 1991-2016

  • Ad Hoc Reviewer, Acta Psychiatrica Scandinavica, Alcoholism: Clinical and Experimental Research, American Journal of Psychiatry, American Journal of Geriatric Psychiatry, Annals of Neurology, Biological Psychiatry, JAMA: Psychiatry, Journal of Abnormal   Psychology, LANCET Psychiatry, Molecular Psychiatry, Nicotine & Tobacco Research,            Psychiatry Research: Neuroimaging, Synapse, 1998-

  • Member, Society for Research on Nicotine and Tobacco, 2002-

  • Member, Society of Biological Psychiatry, 2002-

  • Mentor for Travel Awardees, American College of Neuropsychopharmacology, 2003-

  • Expert Panel Member, Creating an Algorithm for Tailoring Pharmacotherapies for Smoking Cessation, Centre for Addiction and Mental Health, University of Toronto, 2007

  • Member, Programming Committee, Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting, 2007-2009

  • Member and Ad Hoc Member, Neuroscience A (NURA) Grant Review Committee, Department of Veterans                 Affairs, Washington, D.C., 2007-2009; 2012-2015

  • Member, Advocacy Committee, American College of Neuropsychopharmacology, 2008-2012

  • Member, National Institute on Drug Abuse (NIDA) Grant Review Committee ZDA1 RXL-E, Extinction and Pharmacotherapies of Drug Abuse, 2008

  • Faculty Member, UCLA Interdepartmental Ph.D. Program for Neuroscience, 2008-2016

  • Scientific Advisory Board, Psychotherapy Development Center, Yale University, 2008-2010

  • Member, Special Emphasis Panel/Scientific Review Group ZRG1 BDCN-T, National Institute on Drug Abuse, RFA-OD-09-003 Challenge Grant Panel 11, 2009

  • Grant Reviewer, Behavioral Science Track Award for Rapid Transition, NIDA, 2009-2010

  • Member, Risk, Prevention and Intervention for Addictions (RPIA) Scientific Review, 2010-2011

  • Editorial Board, Neuropsychopharmacology, 2010

  • Mentor for Travel Awardees, Society of Biological Psychiatry, 2013-

  • Senior Editor, Addiction, 2013-

  • Member, Publications Committee, American College of Neuropsychopharmacology, 2014-

  • Member, National Institutes of Health, ZRG1 BDCN-W Grant Review Committee, 2015-

  • Member, Addictions Special Interest Group, UCSD, 2016-

  • Applicant Interviewer, UCSD Psychiatry Residency, 2016-


  • BA, English, Vassar College, 1986

  • M.D., Medicine, Tufts University School of Medicine, 1990

  • Residency, Pychiatry, UCLA Neuropsychiatric Institute/UCLA-CHS/West Los Angeles VA Medical Center, 1994

  • Fellowship, Brain Imaging, UCLA Neuropsychiatric Institute and Hospital NIH-Funded Fellowship, UCLA, 1995


  • Goal Sharing Award, “Smoking Cessation Assistance for Mentally Ill Veterans,” Department of Veterans Affairs, 2003

  • Certificate of Leadership, American Cancer Society, 2005

  • Distinguished Fellow, American Psychiatric Association (APA), 2008

  • Certificate of Appreciation, VA Biomedical Laboratory Research and Development and Clinical Science Research and Development Services, 2009

  • Richard Metzner Chair in Clinical Neuropharmacology, 2009-2012

  • Fellow, American College of Neuropsychopharmacology (ACNP), 2010

  • Reviewer Appreciation Award, Neuropsychopharmacology, 2013, 2015


National/Global Website: National Center for Biotechnology Information

bottom of page